August 31, 2009 — Pleural fluid mesothelin is a helpful adjunct to cytology examination in patients with an undiagnosed pleural effusion, according to the results of a study reported in the ...

A more obvious symptom of pleural mesothelioma is fluid buildup in the lungs, but you may not be able to notice it without medical imagery. Why It’s Important to Act Early.

If the amount of pleural fluid remains constant, ... Pembrolizumab Approved With Chemotherapy for Malignant Pleural Mesothelioma; J&J Says It Has Settled Some Talc Claims, ...

A new technique may help clinicians hone in on a diagnosis in patients presenting with a pleural effusion of unknown cause. The study, led by principal investigator Y.C. Gary Lee, Ph.D., appears ...

Malignant pleural mesothelioma (MPM) is a rare but fatal tumour. Although most MPM patients show pleural effusion at even the early stage, it is hard to diagnose as MPM at the early stage because ...

The malignant pleural mesothelioma market is poised for steady growth during the forecast period (2025–2034). The launch of innovative therapies by companies such as AstraZeneca, Polaris ...

The nuclear protein Ki67 is a meaningful biomarker for tumor aggressiveness and for the success of surgical therapy in pleural mesothelioma, a malignant disease of the pleura.

The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

“(Pleural mesothelioma is) really from the lining and when you think about that, in comparison to lung cancer, lung cancer is a cancer of the tissue of your lungs. So, in other words, it’s the ...

Your doctor's office will send samples of your pleural fluid to a lab for testing and let you know about the results. Thoracentesis Complications. Any medical procedure has some risks.

Ms Johnson will be a Mesothelioma UK clinical nurse specialist and will also become the hospital’s first pleural clinical nurse specialist. In her new role, Ms Johnson will be supporting patients ...